Iradimed (IRMD) Other Accumulated Expenses (2013 - 2026)

Iradimed (IRMD) has 14 years of Other Accumulated Expenses data on file, last reported at $427000.0 in Q1 2026.

• On a quarterly basis, Other Accumulated Expenses rose 66.16% year-over-year to $427000.0 in Q1 2026; TTM through Mar 2026 was $427000.0, a 66.16% increase from a year earlier, with the FY2025 full-year figure at $313000.0, down 32.83% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $427000.0, up from $313000.0 in the prior quarter.
• Over the last five years, Other Accumulated Expenses for IRMD reached as high as $466000.0 in Q4 2024 and fell as low as $58587.0 in Q1 2023.
• Historically, Other Accumulated Expenses has averaged $223281.5 across 5 years, with a median of $235370.0 in 2022.
• Across the five-year window, Other Accumulated Expenses tumbled 52.16% in 2023 and jumped 351.37% in 2024, its largest moves.
• Year by year, Other Accumulated Expenses stood at $121919.0 in 2022, then dropped by 15.32% to $103241.0 in 2023, then soared by 351.37% to $466000.0 in 2024, then sank by 32.83% to $313000.0 in 2025, then jumped by 36.42% to $427000.0 in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $427000.0 in Q1 2026, $313000.0 in Q4 2025, and $296207.0 in Q3 2025.